+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Gastritis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Gastritis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Anemia In Chronic Kidney Disease - Epidemiology Forecast to 2032 - Product Thumbnail Image

Anemia In Chronic Kidney Disease - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Idiopathic Short Stature - Epidemiology Forecast to 2032 - Product Thumbnail Image

Idiopathic Short Stature - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Impetigo - Epidemiology Forecast to 2032 - Product Thumbnail Image

Impetigo - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
From
Acute Coronary Syndrome - Epidemiology Forecast to 2032 - Product Thumbnail Image

Acute Coronary Syndrome - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Pulmonary Embolism - Epidemiology Forecast to 2032 - Product Thumbnail Image

Pulmonary Embolism - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Hemorrhoids - Epidemiology Forecast to 2032 - Product Thumbnail Image

Hemorrhoids - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Generalized Pustular Psoriasis - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Generalized Pustular Psoriasis - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Autism Spectrum Disorder (ASD) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Autism Spectrum Disorder (ASD) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Infantile Spasm - Epidemiology Forecast to 2032 - Product Thumbnail Image

Infantile Spasm - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Cardiogenic Shock - Epidemiology Forecast - 2032 - Product Thumbnail Image

Cardiogenic Shock - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Acute Pyelonephritis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Acute Pyelonephritis - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Amebiasis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Amebiasis - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Autosomal Recessive Congenital Ichthyosis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Autosomal Recessive Congenital Ichthyosis - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
From
Brucellosis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Brucellosis - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Cellulitis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Cellulitis - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Chemotherapy-induced nausea and vomiting (CINV) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Chemotherapy-induced nausea and vomiting (CINV) - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Chronic Pain Associated with Painful Diabetic Neuropathy - Epidemiology Forecast - 2032 - Product Thumbnail Image

Chronic Pain Associated with Painful Diabetic Neuropathy - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Pharyngitis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Pharyngitis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more